Literature DB >> 6639128

A common congenital immunodeficiency predisposing to infection and atopy in infancy.

V F Richardson, V F Larcher, J F Price.   

Abstract

Twenty six infants with a congenital immunodeficiency, characterised by failure of their sera to opsonise heat killed bakers' yeast for phagocytosis by normal polymorphonuclear leucocytes, were studied during infancy to determine the frequency of infection and development of atopy. They were compared with controls, matched prospectively for birth date, sex, parental smoking, and atopy and in whom feeding patterns were similar. In 18 of 26 infants the serum defect persisted at age one year. The incidence of infection and atopy, was appreciably greater in the study group than in controls. The 8 children in whom the defect was transient had a similar incidence of infection but a higher incidence of atopy than controls. Eight of 26 mothers and four of 9 fathers tested also had the serum defect, suggesting a strong genetic component. We support the hypothesis that immunodeficiency predisposes to infection and atopy, and that transient immunodeficiency predisposes to atopy.

Entities:  

Mesh:

Year:  1983        PMID: 6639128      PMCID: PMC1628267          DOI: 10.1136/adc.58.10.799

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  13 in total

1.  Predisposing factors and the development of reaginic allergy in infancy.

Authors:  J F Soothill; C R Stokes; M W Turner; A P Norman; B Taylor
Journal:  Clin Allergy       Date:  1976-07

2.  A rapid objective method for measuring the yeast opsonisation activity of serum.

Authors:  R J Levinsky; B A Harvey; S Paleja
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

3.  A defect of the alternative pathway of complement.

Authors:  J F Soothill; B A Harvey
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

4.  Prevention of eczema.

Authors:  D J Matthew; B Taylor; A P Norman; M W Turner
Journal:  Lancet       Date:  1977-02-12       Impact factor: 79.321

5.  Defective yeast opsonization and C2 deficiency in atopic patients.

Authors:  M W Turner; J F Mowbray; B A Harvey; J Brostoff; R S Wells; J F Soothill
Journal:  Clin Exp Immunol       Date:  1978-11       Impact factor: 4.330

6.  The prevalence of immediate positive skin tests to Dermatophagoides pteronyssinus and grass pollen in schoolchildren.

Authors:  R C Godfrey; M Griffiths
Journal:  Clin Allergy       Date:  1976-01

7.  Parental smoking and respiratory illness in infancy.

Authors:  D M Fergusson; L J Horwood; F T Shannon
Journal:  Arch Dis Child       Date:  1980-05       Impact factor: 3.791

8.  Do breast-feeding and delayed introduction of solid foods protect against subsequent atopic eczema?

Authors:  M S Kramer; B Moroz
Journal:  J Pediatr       Date:  1981-04       Impact factor: 4.406

9.  Bacterial and fungal infection in children with fulminant hepatic failure: possible role of opsonisation and complement deficiency.

Authors:  V F Larcher; R J Wyke; A P Mowat; R Williams
Journal:  Gut       Date:  1982-12       Impact factor: 23.059

10.  Yeast opsonisation in children with chronic diarrhoeal states.

Authors:  D C Candy; V F Larcher; J H Tripp; J T Harries; B A Harvey; J F Soothill
Journal:  Arch Dis Child       Date:  1980-03       Impact factor: 3.791

View more
  16 in total

1.  PTEN directly activates the actin depolymerization factor cofilin-1 during PGE2-mediated inhibition of phagocytosis of fungi.

Authors:  C Henrique Serezani; Steve Kane; Alexandra I Medeiros; Ashley M Cornett; Sang-Hoon Kim; Mariana Morato Marques; Sang-Pyo Lee; Casey Lewis; Emilie Bourdonnay; Megan N Ballinger; Eric S White; Marc Peters-Golden
Journal:  Sci Signal       Date:  2012-02-07       Impact factor: 8.192

2.  Deficiency of mannan binding protein--a new complement deficiency syndrome.

Authors:  M W Turner
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

3.  Mannan binding lectin deficiency and concomitant immunodefects.

Authors:  J Aittoniemi; M Baer; E Soppi; T Vesikari; A Miettinen
Journal:  Arch Dis Child       Date:  1998-03       Impact factor: 3.791

4.  The level of mannan-binding protein regulates the binding of complement-derived opsonins to mannan and zymosan at low serum concentrations.

Authors:  M Super; R J Levinsky; M W Turner
Journal:  Clin Exp Immunol       Date:  1990-02       Impact factor: 4.330

5.  Suboptimal C3b/C3bi deposition and defective yeast opsonization. I. Evidence for the absence of essential co-factor activity.

Authors:  M W Turner; N D Seymour; M D Kazatchkine; J F Mowbray
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

6.  Evaluation of C3b/C3bi opsonization and chemiluminescence with selected yeasts and bacteria using sera of different opsonic potential.

Authors:  M W Turner; C Grant; N D Seymour; B Harvey; R J Levinsky
Journal:  Immunology       Date:  1986-05       Impact factor: 7.397

7.  Mannose-binding lectin 2 (MBL2) gene polymorphism in asthma and atopy among adults.

Authors:  J Aittoniemi; H Soranummi; A T Rovio; M Hurme; T Pessi; M Nieminen; J Karjalainen
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

8.  Mannan-binding protein--levels in plasma and upper-airways secretions and frequency of genotypes in children with recurrence of otitis media.

Authors:  P Garred; K Brygge; C H Sørensen; H O Madsen; S Thiel; A Svejgaard
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

Review 9.  Mammalian lectins in activation and clearance mechanisms involving the complement system.

Authors:  K B Reid; M W Turner
Journal:  Springer Semin Immunopathol       Date:  1994

10.  The concentration of the C-type lectin, mannan-binding protein, in human plasma increases during an acute phase response.

Authors:  S Thiel; U Holmskov; L Hviid; S B Laursen; J C Jensenius
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.